Moving one step closer to personalized anesthesia

 

Lausanne, France (May 28, 2021) –EPFL (Ecole Polytechnique Fédérale de Lausanne) researchers have developed a device that can continuously measure the blood concentration of propofol – one of the main compounds used in anesthetics – in patients as they are being operated on.

Anesthesia may be an exact science, but it’s not yet fully personalized. Anesthesiologists use a variety of methods to calculate the right dose for a given patient: clinical studies, medical databases and laboratory measurements, for example. However, every individual responds to anesthetics in a different way, and there’s no way of knowing what that response will be until the anesthetic is administered.

 

Personalizing dosage

Today patients often receive supplemental doses of an anesthetic during their operation based on their reaction. The role of anesthesiologists is to make sure that a patient doesn’t wake up too soon and has no memory of the procedure, but they must use the smallest possible amount of drugs, which can often be taxing on the body. In reality, the supplemental doses are administered with no knowledge of what the actual drug concentration already is in the patient.

To solve that problem, researchers at EPFL’s Integrated Systems Laboratory (LSI) in the School of Engineering, working in association with the Lausanne University Hospital (CHUV) and the Polytechnic University of Turin, have developed a system that can measure propofol concentration in patients as they’re being operated on and adjust the doses they’re administered accordingly. „Scientists have been working for years to develop sensors that can instantly measure blood concentrations of compounds in anesthetized patients, so that doctors can personalize the doses,“ says Sandro Carrara, a professor at the EPFL School of Engineering. „Propofol is one of the main compounds used in anesthesia, but it’s also one of the hardest to measure.“

 

A smart syringe

The researchers‘ device looks like a huge syringe. Its needle contains sensor electrodes that measure propofol concentrations in a patient’s blood, while the electronics for the sensors – developed at LSI – are contained in a central control box. The sensors‘ measurements are analyzed using artificial intelligence.

 

Accurate measurements thanks to machine learning

„The reason why propofol is so hard to measure is that it tends to stick to a needle’s tip, distorting the results,“ says Carrara. His team tried out various methods for resolving this issue before finally deciding on machine learning. Thierry Buclin, pharmacology professor and chief of the CHUV’s clinical pharmacology division, says: „Propofol is one of the best anesthetics out there, but getting the dosage just right can be complicated. So an easy-to-use system that can monitor propofol concentrations in the operating room would be a major step forward in surgery and intensive care.“

The LSI researchers have confirmed the accuracy of their device through in vitro tests on human blood samples. The next step will be to conduct tests in vivo. Their findings have been published in IEEE Transactions on Biomedical Circuits and Systems.

 

 


Ecole Polytechnique Fédérale de Lausanne, 28.05.2021 (tB).

Schlagwörter: ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…